134 related articles for article (PubMed ID: 37194951)
1. Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy.
Li Q; Song Q; Zhao Z; Lin Y; Cheng Y; Karin N; Luan Y
ACS Nano; 2023 Jun; 17(11):10376-10392. PubMed ID: 37194951
[TBL] [Abstract][Full Text] [Related]
2. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
3. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
4. In situ hydrogel enhances non-efferocytic phagocytosis for post-surgical tumor treatment.
Lyu J; Liu H; Chen L; Liu C; Tao J; Yao Y; Li L; Huang Y; Zhou Z
J Control Release; 2023 Nov; 363():402-414. PubMed ID: 37751825
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
Shimizu A; Sawada K; Kimura T
Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
[TBL] [Abstract][Full Text] [Related]
7. Exosome transportation-mediated immunosuppression relief through cascade amplification for enhanced apoptotic body vaccination.
Zhao G; Liu H; Wang Z; Yang H; Zhao H; Zhang Y; Ge K; Wang X; Luo L; Zhou X; Zhang J; Li Z
Acta Biomater; 2022 Nov; 153():529-539. PubMed ID: 36113726
[TBL] [Abstract][Full Text] [Related]
8. M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.
de la Fuente A; Alonso-Alconada L; Costa C; Cueva J; Garcia-Caballero T; Lopez-Lopez R; Abal M
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26150590
[TBL] [Abstract][Full Text] [Related]
9. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
Chen C; Zhang L; Ruan Z
Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
[TBL] [Abstract][Full Text] [Related]
10. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
11. MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer.
Xiong J; He X; Xu Y; Zhang W; Fu F
J Ovarian Res; 2021 Jun; 14(1):74. PubMed ID: 34078414
[TBL] [Abstract][Full Text] [Related]
12. Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer.
Li H; Zeng C; Shu C; Cao Y; Shao W; Zhang M; Cao H; Zhao S
Cell Death Dis; 2022 Dec; 13(12):1028. PubMed ID: 36477408
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
[TBL] [Abstract][Full Text] [Related]
14. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.
Moradi-Chaleshtori M; Shojaei S; Mohammadi-Yeganeh S; Hashemi SM
Life Sci; 2021 Oct; 282():119800. PubMed ID: 34245773
[TBL] [Abstract][Full Text] [Related]
15. Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer.
Tokuda A; Miyake T; Yasukawa D; Ikuta D; Mukaisho KI; Murata S; Shimizu T; Tani M
Anticancer Res; 2021 Mar; 41(3):1327-1339. PubMed ID: 33788724
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier.
Deng G; Qu J; Zhang Y; Che X; Cheng Y; Fan Y; Zhang S; Na D; Liu Y; Qu X
FEBS Lett; 2017 Jul; 591(14):2167-2179. PubMed ID: 28643334
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview.
Cheng H; Wang Z; Fu L; Xu T
Front Oncol; 2019; 9():421. PubMed ID: 31192126
[TBL] [Abstract][Full Text] [Related]
19. Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma.
Guo L; Zhang Y; Yang Z; Peng H; Wei R; Wang C; Feng M
ACS Nano; 2019 Feb; 13(2):1078-1096. PubMed ID: 30608136
[TBL] [Abstract][Full Text] [Related]
20. Biomineralized hydrogel DC vaccine for cancer immunotherapy: A boosting strategy via improving immunogenicity and reversing immune-inhibitory microenvironment.
Huo W; Yang X; Wang B; Cao L; Fang Z; Li Z; Liu H; Liang XJ; Zhang J; Jin Y
Biomaterials; 2022 Sep; 288():121722. PubMed ID: 35963815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
